COYA earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -3.80. Updated 2026-07-23.
Coya Therapeutics (COYA) Research Hub
Coya Therapeutics (COYA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 4.38 USD (-4.99%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.80, market cap 0.08B. This hub links to the full technical, earnings and options research available for COYA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.38 USD (-4.99%) |
| 52-week range | 3.86 USD – 6.21 USD |
| Trend regime | Range |
| 14-day RSI | 38.5 (Bearish) |
| Trailing P/E | -3.80 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for COYA
Covered Call on COYA: how it works, illustrative setup around the real 4.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on COYA: how it works, illustrative setup around the real 4.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on COYA: how it works, illustrative setup around the real 4.38 USD price, max profit/loss, breakeven and when to use it. Educational.
COYA technical analysis: range, last 4.38 USD, RSI 38.5, 52w range 3.86 USD–6.21 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is COYA in?
Coya Therapeutics (COYA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is COYA in an uptrend or downtrend?
As of 2026-09-11, COYA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is COYA's trailing P/E ratio?
COYA's trailing P/E is -3.80, with a market cap of 0.08B. See the earnings research page for full valuation detail.
When does COYA next report earnings?
COYA is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.36 USD.